Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea

Keyphrases

• Inflammatory Bowel Disease 100%
• South Korea 100%
• Mycobacterium Tuberculosis Infection 100%
• National Cohort Study 100%
• Incidence Rate 60%
• Tuberculosis Incidence 60%
• Incidence Data 40%
• Standardized Incidence Ratio 40%
• Number Needed to Screen 40%
• Tuberculosis 30%
• Crohn's Disease 20%
• Ulcerative Colitis Patient 20%
• Anti-tumor Necrosis Factor (anti-TNF) 20%
• Low Incidence 10%
• Korean National Health Insurance 10%
• Immunomodulator 10%
• Corticosteroids 10%
• National Health System 10%
• 5-aminosalicylic Acid (5-ASA) 10%
• Active Tuberculosis 10%
• Anti-TNF Therapy 10%
• Tuberculosis Risk 10%

Medicine and Dentistry

• Patient with Inflammatory Bowel Disease 100%
• Tuberculosis 100%
• Inflammatory Bowel Disease 100%
• Standardized Incidence Ratio 50%
• Tumor Necrosis Factor 37%
• Crohn's Disease 25%
• Ulcerative Colitis 25%
• Drug Therapy 12%
• Clinician 12%
• Acetylsalicylic Acid 12%
• Immunomodulating Agent 12%
• Population 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Tuberculosis 100%
• Standardized Incidence Ratio 40%
• Tumor Necrosis Factor 30%
• Crohn's Disease 20%
• Ulcerative Colitis 20%
• Acetylsalicylic Acid 10%
• Immunomodulating Agent 10%